Acute Wound Care Comprehensive Study by Type (Infection Management, Exudate Management,, Active Wound Care, Therapy Devices), Wounds (Surgical Wounds, Traumatic Wounds), End-user (Long- Term Care Facilities, Home Healthcare, Hospitals and Specialty Wound Care Clinics) Players and Region - Global Market Outlook to 2028

Acute Wound Care Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Acute Wound Care Market Scope
An acute wound is a skin damage that occurs immediately rather than over time. It heals at the conventional wound healing rate, which is predictable and expected. Acute wounds can happen anywhere on the body, and they can range from minor scrapes to major wounds that damage blood vessels, nerves, and muscles.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledSmith and Nephew (United Kingdom), Cardinal Health (United States), Coloplast Corp (Denmark), ConvaTec Inc. (United Kingdom), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (United States), 3M (United States), Braun Melsungen AG (Germany) and Tissue Regenix (United States)
CAGR%


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Acute Wound Care market throughout the predicted period.

Smith and Nephew (United Kingdom), Cardinal Health (United States), Coloplast Corp (Denmark), ConvaTec Inc. (United Kingdom), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (United States), 3M (United States), Braun Melsungen AG (Germany) and Tissue Regenix (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Acute Wound Care market by Type and Region with country level break-up.

On the basis of geography, the market of Acute Wound Care has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

In 2019, Axio Biosolutions Pvt. Ltd., a medtech R&D, and Manufacturing Company concentrated on surgical and wound care products declared the launch of MaxioCel, an advanced Ground-breaking wound care dressing made of chitosan.


Influencing Trend:
Developing new varieties of wounds

Market Growth Drivers:
Growing chronic diseases like cancer, stroke and heart attack

Challenges:
Lack of awareness of using products

Restraints:
Lack of awareness of using products

Opportunities:
Rising Government Investment in wound care

Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Infection Management
  • Exudate Management,
  • Active Wound Care
  • Therapy Devices
By Wounds
  • Surgical Wounds
  • Traumatic Wounds

By End-user
  • Long- Term Care Facilities
  • Home Healthcare
  • Hospitals and Specialty Wound Care Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing chronic diseases like cancer, stroke and heart attack
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness of using products
    • 3.4. Market Trends
      • 3.4.1. Developing new varieties of wounds
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Acute Wound Care, by Type, Wounds, End-user and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Acute Wound Care (Value)
      • 5.2.1. Global Acute Wound Care by: Type (Value)
        • 5.2.1.1. Infection Management
        • 5.2.1.2. Exudate Management,
        • 5.2.1.3. Active Wound Care
        • 5.2.1.4. Therapy Devices
      • 5.2.2. Global Acute Wound Care by: Wounds (Value)
        • 5.2.2.1. Surgical Wounds
        • 5.2.2.2. Traumatic Wounds
      • 5.2.3. Global Acute Wound Care by: End-user (Value)
        • 5.2.3.1. Long- Term Care Facilities
        • 5.2.3.2. Home Healthcare
        • 5.2.3.3. Hospitals and Specialty Wound Care Clinics
      • 5.2.4. Global Acute Wound Care Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Acute Wound Care: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Smith and Nephew (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cardinal Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Coloplast Corp (Denmark)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ConvaTec Inc. (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mölnlycke Health Care AB (Sweden)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Integra LifeSciences Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. 3M (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Braun Melsungen AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tissue Regenix (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Acute Wound Care Sale, by Type, Wounds, End-user and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Acute Wound Care (Value)
      • 7.2.1. Global Acute Wound Care by: Type (Value)
        • 7.2.1.1. Infection Management
        • 7.2.1.2. Exudate Management,
        • 7.2.1.3. Active Wound Care
        • 7.2.1.4. Therapy Devices
      • 7.2.2. Global Acute Wound Care by: Wounds (Value)
        • 7.2.2.1. Surgical Wounds
        • 7.2.2.2. Traumatic Wounds
      • 7.2.3. Global Acute Wound Care by: End-user (Value)
        • 7.2.3.1. Long- Term Care Facilities
        • 7.2.3.2. Home Healthcare
        • 7.2.3.3. Hospitals and Specialty Wound Care Clinics
      • 7.2.4. Global Acute Wound Care Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Acute Wound Care: by Type(USD Million)
  • Table 2. Acute Wound Care Infection Management , by Region USD Million (2017-2022)
  • Table 3. Acute Wound Care Exudate Management, , by Region USD Million (2017-2022)
  • Table 4. Acute Wound Care Active Wound Care , by Region USD Million (2017-2022)
  • Table 5. Acute Wound Care Therapy Devices , by Region USD Million (2017-2022)
  • Table 6. Acute Wound Care: by Wounds(USD Million)
  • Table 7. Acute Wound Care Surgical Wounds , by Region USD Million (2017-2022)
  • Table 8. Acute Wound Care Traumatic Wounds , by Region USD Million (2017-2022)
  • Table 9. Acute Wound Care: by End-user(USD Million)
  • Table 10. Acute Wound Care Long- Term Care Facilities , by Region USD Million (2017-2022)
  • Table 11. Acute Wound Care Home Healthcare , by Region USD Million (2017-2022)
  • Table 12. Acute Wound Care Hospitals and Specialty Wound Care Clinics , by Region USD Million (2017-2022)
  • Table 13. South America Acute Wound Care, by Country USD Million (2017-2022)
  • Table 14. South America Acute Wound Care, by Type USD Million (2017-2022)
  • Table 15. South America Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 16. South America Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 17. Brazil Acute Wound Care, by Type USD Million (2017-2022)
  • Table 18. Brazil Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 19. Brazil Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 20. Argentina Acute Wound Care, by Type USD Million (2017-2022)
  • Table 21. Argentina Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 22. Argentina Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 23. Rest of South America Acute Wound Care, by Type USD Million (2017-2022)
  • Table 24. Rest of South America Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 25. Rest of South America Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 26. Asia Pacific Acute Wound Care, by Country USD Million (2017-2022)
  • Table 27. Asia Pacific Acute Wound Care, by Type USD Million (2017-2022)
  • Table 28. Asia Pacific Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 29. Asia Pacific Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 30. China Acute Wound Care, by Type USD Million (2017-2022)
  • Table 31. China Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 32. China Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 33. Japan Acute Wound Care, by Type USD Million (2017-2022)
  • Table 34. Japan Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 35. Japan Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 36. India Acute Wound Care, by Type USD Million (2017-2022)
  • Table 37. India Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 38. India Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 39. South Korea Acute Wound Care, by Type USD Million (2017-2022)
  • Table 40. South Korea Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 41. South Korea Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 42. Taiwan Acute Wound Care, by Type USD Million (2017-2022)
  • Table 43. Taiwan Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 44. Taiwan Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 45. Australia Acute Wound Care, by Type USD Million (2017-2022)
  • Table 46. Australia Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 47. Australia Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Acute Wound Care, by Type USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 51. Europe Acute Wound Care, by Country USD Million (2017-2022)
  • Table 52. Europe Acute Wound Care, by Type USD Million (2017-2022)
  • Table 53. Europe Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 54. Europe Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 55. Germany Acute Wound Care, by Type USD Million (2017-2022)
  • Table 56. Germany Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 57. Germany Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 58. France Acute Wound Care, by Type USD Million (2017-2022)
  • Table 59. France Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 60. France Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 61. Italy Acute Wound Care, by Type USD Million (2017-2022)
  • Table 62. Italy Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 63. Italy Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 64. United Kingdom Acute Wound Care, by Type USD Million (2017-2022)
  • Table 65. United Kingdom Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 66. United Kingdom Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 67. Netherlands Acute Wound Care, by Type USD Million (2017-2022)
  • Table 68. Netherlands Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 69. Netherlands Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 70. Rest of Europe Acute Wound Care, by Type USD Million (2017-2022)
  • Table 71. Rest of Europe Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 72. Rest of Europe Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 73. MEA Acute Wound Care, by Country USD Million (2017-2022)
  • Table 74. MEA Acute Wound Care, by Type USD Million (2017-2022)
  • Table 75. MEA Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 76. MEA Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 77. Middle East Acute Wound Care, by Type USD Million (2017-2022)
  • Table 78. Middle East Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 79. Middle East Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 80. Africa Acute Wound Care, by Type USD Million (2017-2022)
  • Table 81. Africa Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 82. Africa Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 83. North America Acute Wound Care, by Country USD Million (2017-2022)
  • Table 84. North America Acute Wound Care, by Type USD Million (2017-2022)
  • Table 85. North America Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 86. North America Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 87. United States Acute Wound Care, by Type USD Million (2017-2022)
  • Table 88. United States Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 89. United States Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 90. Canada Acute Wound Care, by Type USD Million (2017-2022)
  • Table 91. Canada Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 92. Canada Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 93. Mexico Acute Wound Care, by Type USD Million (2017-2022)
  • Table 94. Mexico Acute Wound Care, by Wounds USD Million (2017-2022)
  • Table 95. Mexico Acute Wound Care, by End-user USD Million (2017-2022)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Acute Wound Care: by Type(USD Million)
  • Table 106. Acute Wound Care Infection Management , by Region USD Million (2023-2028)
  • Table 107. Acute Wound Care Exudate Management, , by Region USD Million (2023-2028)
  • Table 108. Acute Wound Care Active Wound Care , by Region USD Million (2023-2028)
  • Table 109. Acute Wound Care Therapy Devices , by Region USD Million (2023-2028)
  • Table 110. Acute Wound Care: by Wounds(USD Million)
  • Table 111. Acute Wound Care Surgical Wounds , by Region USD Million (2023-2028)
  • Table 112. Acute Wound Care Traumatic Wounds , by Region USD Million (2023-2028)
  • Table 113. Acute Wound Care: by End-user(USD Million)
  • Table 114. Acute Wound Care Long- Term Care Facilities , by Region USD Million (2023-2028)
  • Table 115. Acute Wound Care Home Healthcare , by Region USD Million (2023-2028)
  • Table 116. Acute Wound Care Hospitals and Specialty Wound Care Clinics , by Region USD Million (2023-2028)
  • Table 117. South America Acute Wound Care, by Country USD Million (2023-2028)
  • Table 118. South America Acute Wound Care, by Type USD Million (2023-2028)
  • Table 119. South America Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 120. South America Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 121. Brazil Acute Wound Care, by Type USD Million (2023-2028)
  • Table 122. Brazil Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 123. Brazil Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 124. Argentina Acute Wound Care, by Type USD Million (2023-2028)
  • Table 125. Argentina Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 126. Argentina Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 127. Rest of South America Acute Wound Care, by Type USD Million (2023-2028)
  • Table 128. Rest of South America Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 129. Rest of South America Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 130. Asia Pacific Acute Wound Care, by Country USD Million (2023-2028)
  • Table 131. Asia Pacific Acute Wound Care, by Type USD Million (2023-2028)
  • Table 132. Asia Pacific Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 133. Asia Pacific Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 134. China Acute Wound Care, by Type USD Million (2023-2028)
  • Table 135. China Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 136. China Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 137. Japan Acute Wound Care, by Type USD Million (2023-2028)
  • Table 138. Japan Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 139. Japan Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 140. India Acute Wound Care, by Type USD Million (2023-2028)
  • Table 141. India Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 142. India Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 143. South Korea Acute Wound Care, by Type USD Million (2023-2028)
  • Table 144. South Korea Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 145. South Korea Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 146. Taiwan Acute Wound Care, by Type USD Million (2023-2028)
  • Table 147. Taiwan Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 148. Taiwan Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 149. Australia Acute Wound Care, by Type USD Million (2023-2028)
  • Table 150. Australia Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 151. Australia Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 152. Rest of Asia-Pacific Acute Wound Care, by Type USD Million (2023-2028)
  • Table 153. Rest of Asia-Pacific Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 154. Rest of Asia-Pacific Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 155. Europe Acute Wound Care, by Country USD Million (2023-2028)
  • Table 156. Europe Acute Wound Care, by Type USD Million (2023-2028)
  • Table 157. Europe Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 158. Europe Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 159. Germany Acute Wound Care, by Type USD Million (2023-2028)
  • Table 160. Germany Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 161. Germany Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 162. France Acute Wound Care, by Type USD Million (2023-2028)
  • Table 163. France Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 164. France Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 165. Italy Acute Wound Care, by Type USD Million (2023-2028)
  • Table 166. Italy Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 167. Italy Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 168. United Kingdom Acute Wound Care, by Type USD Million (2023-2028)
  • Table 169. United Kingdom Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 170. United Kingdom Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 171. Netherlands Acute Wound Care, by Type USD Million (2023-2028)
  • Table 172. Netherlands Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 173. Netherlands Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 174. Rest of Europe Acute Wound Care, by Type USD Million (2023-2028)
  • Table 175. Rest of Europe Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 176. Rest of Europe Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 177. MEA Acute Wound Care, by Country USD Million (2023-2028)
  • Table 178. MEA Acute Wound Care, by Type USD Million (2023-2028)
  • Table 179. MEA Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 180. MEA Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 181. Middle East Acute Wound Care, by Type USD Million (2023-2028)
  • Table 182. Middle East Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 183. Middle East Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 184. Africa Acute Wound Care, by Type USD Million (2023-2028)
  • Table 185. Africa Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 186. Africa Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 187. North America Acute Wound Care, by Country USD Million (2023-2028)
  • Table 188. North America Acute Wound Care, by Type USD Million (2023-2028)
  • Table 189. North America Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 190. North America Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 191. United States Acute Wound Care, by Type USD Million (2023-2028)
  • Table 192. United States Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 193. United States Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 194. Canada Acute Wound Care, by Type USD Million (2023-2028)
  • Table 195. Canada Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 196. Canada Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 197. Mexico Acute Wound Care, by Type USD Million (2023-2028)
  • Table 198. Mexico Acute Wound Care, by Wounds USD Million (2023-2028)
  • Table 199. Mexico Acute Wound Care, by End-user USD Million (2023-2028)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Acute Wound Care: by Type USD Million (2017-2022)
  • Figure 5. Global Acute Wound Care: by Wounds USD Million (2017-2022)
  • Figure 6. Global Acute Wound Care: by End-user USD Million (2017-2022)
  • Figure 7. South America Acute Wound Care Share (%), by Country
  • Figure 8. Asia Pacific Acute Wound Care Share (%), by Country
  • Figure 9. Europe Acute Wound Care Share (%), by Country
  • Figure 10. MEA Acute Wound Care Share (%), by Country
  • Figure 11. North America Acute Wound Care Share (%), by Country
  • Figure 12. Global Acute Wound Care share by Players 2022 (%)
  • Figure 13. Global Acute Wound Care share by Players (Top 3) 2022(%)
  • Figure 14. Global Acute Wound Care share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Smith and Nephew (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. Smith and Nephew (United Kingdom) Revenue: by Geography 2022
  • Figure 18. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 19. Cardinal Health (United States) Revenue: by Geography 2022
  • Figure 20. Coloplast Corp (Denmark) Revenue, Net Income and Gross profit
  • Figure 21. Coloplast Corp (Denmark) Revenue: by Geography 2022
  • Figure 22. ConvaTec Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. ConvaTec Inc. (United Kingdom) Revenue: by Geography 2022
  • Figure 24. Mölnlycke Health Care AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 25. Mölnlycke Health Care AB (Sweden) Revenue: by Geography 2022
  • Figure 26. Integra LifeSciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Integra LifeSciences Corporation (United States) Revenue: by Geography 2022
  • Figure 28. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 29. 3M (United States) Revenue: by Geography 2022
  • Figure 30. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Braun Melsungen AG (Germany) Revenue: by Geography 2022
  • Figure 32. Tissue Regenix (United States) Revenue, Net Income and Gross profit
  • Figure 33. Tissue Regenix (United States) Revenue: by Geography 2022
  • Figure 34. Global Acute Wound Care: by Type USD Million (2023-2028)
  • Figure 35. Global Acute Wound Care: by Wounds USD Million (2023-2028)
  • Figure 36. Global Acute Wound Care: by End-user USD Million (2023-2028)
  • Figure 37. South America Acute Wound Care Share (%), by Country
  • Figure 38. Asia Pacific Acute Wound Care Share (%), by Country
  • Figure 39. Europe Acute Wound Care Share (%), by Country
  • Figure 40. MEA Acute Wound Care Share (%), by Country
  • Figure 41. North America Acute Wound Care Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Smith and Nephew (United Kingdom)
  • Cardinal Health (United States)
  • Coloplast Corp (Denmark)
  • ConvaTec Inc. (United Kingdom)
  • Mölnlycke Health Care AB (Sweden)
  • Integra LifeSciences Corporation (United States)
  • 3M (United States)
  • Braun Melsungen AG (Germany)
  • Tissue Regenix (United States)
Select User Access Type

Key Highlights of Report


May 2023 213 Pages 87 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Acute Wound Care Market are by type [Infection Management, Exudate Management,, Active Wound Care and Therapy Devices], by end use application [].
The Acute Wound Care Market is gaining popularity and expected to see strong valuation by 2028.
  • Growing chronic diseases like cancer, stroke and heart attack

Know More About Global Acute Wound Care Market Report?